Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Naito, Yoshiro ^a   Sawada, Hisashi ^a   Oboshi, Makiko ^a   Fujii, Aya ^a   Hirotani, Shinichi ^a   Iwasaku, Toshihiro ^a   Okuhara, Yoshitaka ^a   Eguchi, Akiyo ^a   Morisawa, Daisuke ^a   Ohyanagi, Mitsumasa ^a   Tsujino, Takeshi ^a   Masuyama, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CD71 ANTIGEN; HEPCIDIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; HYPERTENSION; HYPERTENSIVE NEPHROPATHY; IRON ABSORPTION; IRON INTAKE; IRON RESTRICTION; IRON STORAGE; IRON TRANSPORT; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY STRUCTURE; MALE; NEPHROSCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SALT INTAKE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL RATE; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; CATION TRANSPORT PROTEINS; HYPERTENSION, RENAL; IRON; KIDNEY; MALE; NEPHRITIS; NEPHROSCLEROSIS; RATS; RATS, INBRED SHR; RECEPTORS, TRANSFERRIN; SODIUM CHLORIDE, DIETARY;

EID: 84885094738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075906     Document Type: Article

References (14)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
2. Luke RG, (1999) Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant 14: 2271-2278.
3. Nankivell BJ, Boadle RA, Harris DC, (1992) Iron accumulation in human chronic renal disease. Am J Kidney Dis 20: 580-584.
4. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, et al. (2005) Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16: 3631-3641.
5. Nankivell BJ, Chen J, Boadle RA, Harris DC, (1994) The role of tubular iron accumulation in the remnant kidney. J Am Soc Nephrol 4: 1598-1607.
6. Harris DC, Tay C, Nankivell BJ, (1994) Lysosomal iron accumulation and tubular damage in rat puromycin nephrosis and ageing. Clin Exp Pharmacol Physiol 21: 73-81.
7. Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, et al. (2012) Effect of Iron Restriction on Renal Damage and Mineralocorticoid Receptor Signaling in a Rat Model of Chronic Kidney Disease. J Hypertens 30: 2192-2201.
8. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, et al. (2009) Adaptive response of the heart to long term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296: H585-H593.
9. Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, et al. (2011) Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats. Hypertension 57: 497-504.
10. Pillebout E, Weitzman JB, Burtin M, Martino C, Federici P, et al. (2003) JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 112: 843-852.
11. Antonios TF, MacGregor GA, (1996) Salt-more adverse effects. Lancet 348: 250-251.
12. Camargo MJ, von Lutterotti N, Campbell WG Jr, Pecker MS, James GD, et al. (1993) Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J Hypertens 11: 31-40.
13. Fishbane S (2003) Safety in iron management. Am J Kidney Dis 41 (5 suppl): 18-26.
14. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML, (2006) The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clinical Immunology 121: 144-158.